{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:18:20Z","timestamp":1783199900404,"version":"3.54.6"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,22]],"date-time":"2027-05-22T00:00:00Z","timestamp":1810944000000},"content-version":"am","delay-in-days":263,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH048514"],"award-info":[{"award-number":["MH048514"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH085061"],"award-info":[{"award-number":["MH085061"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH062185"],"award-info":[{"award-number":["MH062185"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH040695"],"award-info":[{"award-number":["MH040695"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH074813"],"award-info":[{"award-number":["MH074813"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH090964"],"award-info":[{"award-number":["MH090964"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH067015"],"award-info":[{"award-number":["MH067015"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["MH01997"],"award-info":[{"award-number":["MH01997"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001455","name":"American Foundation for Suicide Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Psychiatric Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jpsychires.2026.05.028","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:02:16Z","timestamp":1778860936000},"page":"123-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Elevated serotonin 1A receptor binding in borderline personality disorder co-morbid with major depressive episodes appears attributable to major depression alone"],"prefix":"10.1016","volume":"200","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7378-4262","authenticated-orcid":false,"given":"M.","family":"Elizabeth Sublette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4934-1766","authenticated-orcid":false,"given":"Abigail","family":"Byrnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Todd Ogden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6510-0676","authenticated-orcid":false,"given":"Francesca","family":"Zanderigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ainsley","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Oquendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"John Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey M.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jpsychires.2026.05.028_bib1","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jpsychires.2010.02.012","article-title":"Cortisol responses to ipsapirone challenge correlate with aggression, while basal cortisol levels correlate with impulsivity, in personality disorder and healthy volunteer subjects","volume":"44","author":"Almeida","year":"2010","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jpsychires.2026.05.028_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"key":"10.1016\/j.jpsychires.2026.05.028_bib3","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2466\/pr0.1965.16.2.547","article-title":"Factor analysis of some psychometric measures of impulsiveness and anxiety","volume":"16","author":"Barratt","year":"1965","journal-title":"Psychol. Rep."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.05.028_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1037\/0022-006X.47.2.343","article-title":"Assessment of suicidal intention: the scale for suicide ideation","volume":"47","author":"Beck","year":"1979","journal-title":"J. Consult. Clin. Psychol."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.05.028_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41398-022-02285-2","article-title":"The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective","volume":"13","author":"Boschloo","year":"2023","journal-title":"Transl. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2026.05.028_bib6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/ajp.139.6.741","article-title":"Aggression, suicide, and serotonin: relationships to CSF amine metabolites","volume":"139","author":"Brown","year":"1982","journal-title":"Am. J. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.05.028_bib7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0165-1781(79)90053-2","article-title":"Aggression in humans correlates with cerebrospinal fluid amine metabolites","volume":"1","author":"Brown","year":"1979","journal-title":"Psychiatry Res."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.05.028_bib8","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/s002130050061","article-title":"Ipsapirone challenge in aggressive men shows an inverse correlation between 5-HT1A receptor function and aggression","volume":"148","author":"Cleare","year":"2000","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.05.028_bib9","first-page":"393","article-title":"Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans","volume":"26","author":"Coccaro","year":"1990","journal-title":"Psychopharmacol. Bull."},{"issue":"7","key":"10.1016\/j.jpsychires.2026.05.028_bib10","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0006-3223(97)00309-0","article-title":"Serotonin function and antiaggressive response to fluoxetine: a pilot study","volume":"42","author":"Coccaro","year":"1997","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.05.028_bib11","first-page":"151","article-title":"Fluoxetine trial in borderline personality disorder","volume":"26","author":"Cornelius","year":"1990","journal-title":"Psychopharmacol. Bull."},{"issue":"7","key":"10.1016\/j.jpsychires.2026.05.028_bib12","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1038\/jcbfm.2009.49","article-title":"Modeling considerations for in vivo quantification of the dopamine transporter using [(11)C]PE2I and positron emission tomography","volume":"29","author":"DeLorenzo","year":"2009","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.05.028_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/mp.2011.159","article-title":"5-HT(2B) receptors are required for serotonin-selective antidepressant actions","volume":"17","author":"Diaz","year":"2012","journal-title":"Mol. Psychiatr."},{"issue":"10","key":"10.1016\/j.jpsychires.2026.05.028_bib14","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0006-3223(99)00189-4","article-title":"PET imaging of serotonin 1A receptor binding in depression","volume":"46","author":"Drevets","year":"1999","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.jpsychires.2026.05.028_bib15","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.nucmedbio.2007.06.008","article-title":"Serotonin-1A receptor imaging in recurrent depression: replication and literature review","volume":"34","author":"Drevets","year":"2007","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jpsychires.2026.05.028_bib16","series-title":"Biometrics Research Department","article-title":"Structured clinical interview for DSM-IV axis I disorders - patient edition","author":"First","year":"1996"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.05.028_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0014-2999(95)00234-C","article-title":"A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635","volume":"281","author":"Forster","year":"1995","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.05.028_bib18","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00213-013-3389-x","article-title":"5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function","volume":"231","author":"Garcia-Garcia","year":"2014","journal-title":"Psychopharmacology"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.05.028_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.biopsych.2012.11.012","article-title":"Antidepressant treatment reduces serotonin-1A autoreceptor binding in major depressive disorder","volume":"74","author":"Gray","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.05.028_bib20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton","year":"1960","journal-title":"J. Neurol. Neurosurg. Psychiatr."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.05.028_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1034\/j.1601-5215.2002.140203.x","article-title":"Serotonin, personality and borderline personality disorder","volume":"14","author":"Hansenne","year":"2002","journal-title":"Acta Neuropsychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.05.028_bib22","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/mp.2015.53","article-title":"Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression","volume":"21","author":"Hieronymus","year":"2015","journal-title":"Mol. Psychiatry"},{"issue":"7","key":"10.1016\/j.jpsychires.2026.05.028_bib23","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0969-8051(99)00056-6","article-title":"An improved one-pot procedure for the preparation of [11C-carbonyl]-WAY100635","volume":"26","author":"Hwang","year":"1999","journal-title":"Nucl. Med. Biol."},{"issue":"9","key":"10.1016\/j.jpsychires.2026.05.028_bib24","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","article-title":"Consensus nomenclature for in vivo imaging of reversibly binding radioligands","volume":"27","author":"Innis","year":"2007","journal-title":"J. Cerebral Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.05.028_bib25","first-page":"137","article-title":"An open trial of sertraline in personality disordered patients with impulsive aggression","volume":"55","author":"Kavoussi","year":"1994","journal-title":"J. Clin. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.05.028_bib26","series-title":"Psychopharmacology: The Fourth Generation of Progress","first-page":"1919","article-title":"Violence and aggression","author":"Mann","year":"1995"},{"issue":"8","key":"10.1016\/j.jpsychires.2026.05.028_bib27","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1176\/ajp.148.8.1064","article-title":"Fluoxetine in the treatment of borderline and schizotypal personality disorders","volume":"148","author":"Markovitz","year":"1991","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.jpsychires.2026.05.028_bib28","article-title":"PET imaging of the serotonin 1A receptor in major depressive disorder: hierarchical multivariate analysis of [ (11) C]WAY100635 overcomes outcome measure discrepancies","volume":"2","author":"Matheson","year":"2024","journal-title":"Imaging Neurosci (Camb)"},{"issue":"12","key":"10.1016\/j.jpsychires.2026.05.028_bib29","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1038\/sj.npp.1300556","article-title":"Serotonin 1A receptor binding and treatment response in late-life depression","volume":"29","author":"Meltzer","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.05.028_bib30","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0091-3057(98)00171-3","article-title":"Antiaggresive and anxiolytic effects of gepirone in mice, and their attenuation by WAY 100635","volume":"62","author":"Mendoza","year":"1999","journal-title":"Pharmacol., Biochem. Behav."},{"issue":"6","key":"10.1016\/j.jpsychires.2026.05.028_bib31","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1139\/jpn.0847","article-title":"Serotonin2A receptor binding potential in people with aggressive and violent behaviour","volume":"33","author":"Meyer","year":"2008","journal-title":"J. Psychiatr. Neurosci."},{"key":"10.1016\/j.jpsychires.2026.05.028_bib32","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1196\/annals.1330.021","article-title":"Escalated aggressive behavior: new pharmacotherapeutic approaches and opportunities","volume":"1036","author":"Miczek","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"12","key":"10.1016\/j.jpsychires.2026.05.028_bib33","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2967\/jnumed.110.076257","article-title":"In vivo quantification of human serotonin 1A receptor using 11C-CUMI-101, an agonist PET radiotracer","volume":"51","author":"Milak","year":"2010","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.jpsychires.2026.05.028_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.pscychresns.2018.04.002","article-title":"Higher 5-HT1A autoreceptor binding as an endophenotype for major depressive disorder identified in high risk offspring - a pilot study","volume":"276","author":"Milak","year":"2018","journal-title":"Psychiatry Res. Neuroimaging."},{"issue":"10","key":"10.1016\/j.jpsychires.2026.05.028_bib35","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1038\/npp.2009.54","article-title":"Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality","volume":"34","author":"Miller","year":"2009","journal-title":"Neuropsychopharmacology"},{"issue":"3\u20134","key":"10.1016\/j.jpsychires.2026.05.028_bib36","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00213-004-1913-8","article-title":"Fluoxetine increases relative metabolic rate in prefrontal cortex in impulsive aggression","volume":"176","author":"New","year":"2004","journal-title":"Psychopharmacology"},{"issue":"7","key":"10.1016\/j.jpsychires.2026.05.028_bib37","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/archpsyc.59.7.621","article-title":"Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression","volume":"59","author":"New","year":"2002","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.jpsychires.2026.05.028_bib38","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/0278-5846(89)90040-7","article-title":"Fluoxetine in borderline personality disorder","volume":"13","author":"Norden","year":"1989","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatr."},{"issue":"1","key":"10.1016\/j.jpsychires.2026.05.028_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/biostatistics\/kxi044","article-title":"Estimation in regression models with externally estimated parameters","volume":"7","author":"Ogden","year":"2005","journal-title":"Biostatistics"},{"issue":"6","key":"10.1016\/j.jpsychires.2026.05.028_bib40","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/sj.npp.1300689","article-title":"Positron emission tomography of regional brain metabolic responses to a serotonergic challenge in major depressive disorder with and without borderline personality disorder","volume":"30","author":"Oquendo","year":"2005","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jpsychires.2026.05.028_bib41","series-title":"Standardized Evaluation in Clinical Practice","first-page":"103","article-title":"Risk factors for suicidal behavior: utility and limitations of research instruments","author":"Oquendo","year":"2003"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.05.028_bib42","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.biopsych.2005.06.037","article-title":"Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide","volume":"59","author":"Oquendo","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"10","key":"10.1016\/j.jpsychires.2026.05.028_bib43","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1001\/jamapsychiatry.2016.1478","article-title":"Positron emission tomographic imaging of the serotonergic system and prediction of risk and lethality of future suicidal behavior","volume":"73","author":"Oquendo","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.05.028_bib44","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.biopsych.2010.03.023","article-title":"Higher serotonin 1A binding in a second major depression cohort: modeling and reference region considerations","volume":"68","author":"Parsey","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.05.028_bib45","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0006-8993(02)03243-2","article-title":"Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635","volume":"954","author":"Parsey","year":"2002","journal-title":"Brain Res."},{"issue":"7","key":"10.1016\/j.jpsychires.2026.05.028_bib46","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00004647-200007000-00011","article-title":"Validation and reproducibility of measurement of 5-HT1A receptor parameters with [carbonyl-11C]WAY-100635 in humans: comparison of arterial and reference tisssue input functions","volume":"20","author":"Parsey","year":"2000","journal-title":"J. Cerebr. Blood Flow Metabol."},{"issue":"8","key":"10.1016\/j.jpsychires.2026.05.028_bib47","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1038\/sj.npp.1300992","article-title":"Higher 5-HT1A receptor binding potential during a major depressive episode predicts poor treatment response: Preliminary data from a naturalistic study","volume":"31","author":"Parsey","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.05.028_bib48","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.biopsych.2005.06.016","article-title":"Altered serotonin 1A binding in major depression: A [carbonyl-C-11]WAY100635 positron emission tomography study","volume":"59","author":"Parsey","year":"2006","journal-title":"Biol. Psychiatry"},{"issue":"7","key":"10.1016\/j.jpsychires.2026.05.028_bib49","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1097\/00004647-200007000-00011","article-title":"Validation and reproducibility of measurement of 5-HT 1A receptor parameters with [carbonyl - 11 C]WAY-100635 in humans: Comparison of arterial and reference tissue input functions","volume":"20","author":"Parsey","year":"2000","journal-title":"J. Cerebral Blood Flow Metab."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.05.028_bib50","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2174\/1570159X12666140828221720","article-title":"Fluoxetine and all other SSRIs are 5-HT2B agonists - importance for their therapeutic effects","volume":"12","author":"Peng","year":"2014","journal-title":"Curr. Neuropharmacol."},{"issue":"12","key":"10.1016\/j.jpsychires.2026.05.028_bib51","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1176\/appi.ajp.159.12.2048","article-title":"SSRI treatment of borderline personality disorder: a randomized, placebo-controlled clinical trial for female patients with borderline personality disorder","volume":"159","author":"Rinne","year":"2002","journal-title":"Am. J. Psychiatr."},{"issue":"12","key":"10.1016\/j.jpsychires.2026.05.028_bib52","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/j.biopsych.2010.03.013","article-title":"Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients","volume":"67","author":"Rosell","year":"2010","journal-title":"Biol. Psychiatry"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.05.028_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004714-199502000-00005","article-title":"Effect of fluoxetine on anger in symptomatic volunteers with borderline personality disorder","volume":"15","author":"Salzman","year":"1995","journal-title":"J. Clin. Psychopharmacol."},{"issue":"2","key":"10.1016\/j.jpsychires.2026.05.028_bib54","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/archpsyc.57.2.174","article-title":"Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment","volume":"57","author":"Sargent","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.05.028_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2023.103839","article-title":"Adjunctive antidepressants for the treatment of bipolar depression: An updated meta-analysis of randomized clinical trials","volume":"91","author":"Shafiee","year":"2024","journal-title":"Asian J. Psychiatr."},{"issue":"4","key":"10.1016\/j.jpsychires.2026.05.028_bib56","first-page":"583","article-title":"Comorbidity of borderline personality disorder: current status and future directions","volume":"41","author":"Shah","year":"2018","journal-title":"Psychiatr. Clin."},{"issue":"5","key":"10.1016\/j.jpsychires.2026.05.028_bib57","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0893-133X(98)00111-0","article-title":"d,l-fenfluramine response in impulsive personality disorder assessed with [18F]fluorodeoxyglucose positron emission tomography","volume":"20","author":"Siever","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.05.028_bib58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4088\/JCP.v65n0314","article-title":"Combined dialectical behavior therapy and fluoxetine in the treatment of borderline personality disorder","volume":"65","author":"Simpson","year":"2004","journal-title":"J. Clin. Psychiatr."},{"issue":"3","key":"10.1016\/j.jpsychires.2026.05.028_bib59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pscychresns.2014.03.008","article-title":"Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder","volume":"222","author":"Soloff","year":"2014","journal-title":"Psychiatry Res."},{"issue":"6","key":"10.1016\/j.jpsychires.2026.05.028_bib60","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0006-3223(99)00202-4","article-title":"A fenfluramine-activated FDG-PET study of borderline personality disorder","volume":"47","author":"Soloff","year":"2000","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.05.028_bib61","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/da.22019","article-title":"Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635","volume":"30","author":"Sullivan","year":"2013","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.jpsychires.2026.05.028_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopsych.2009.01.028","article-title":"Positron emission tomography quantification of Serotonin-1A receptor binding in medication-free bipolar depression","author":"Sullivan","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jpsychires.2026.05.028_bib63","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.biopsych.2009.01.028","article-title":"Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression","volume":"66","author":"Sullivan","year":"2009","journal-title":"Biol. Psychiatry"},{"issue":"2","key":"10.1016\/j.jpsychires.2026.05.028_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/jamapsychiatry.2014.2406","article-title":"Positron emission tomography quantification of serotonin1A receptor binding in suicide attempters with major depressive disorder","volume":"72","author":"Sullivan","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.05.028_bib65","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/7854_2011_191","article-title":"Behavioral and pharmacogenetics of aggressive behavior","volume":"12","author":"Takahashi","year":"2012","journal-title":"Curr Top Behav Neurosci"},{"issue":"1","key":"10.1016\/j.jpsychires.2026.05.028_bib66","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12888-016-1025-0","article-title":"Serotonin-1A receptor alterations in depression: a meta-analysis of molecular imaging studies","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jpsychires.2026.05.028_bib67","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1002\/hbm.20687","article-title":"Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects","volume":"30","author":"Witte","year":"2009","journal-title":"Hum. Brain Mapp."}],"container-title":["Journal of Psychiatric Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626002797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022395626002797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T21:14:35Z","timestamp":1783199675000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022395626002797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":67,"alternative-id":["S0022395626002797"],"URL":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.05.028","relation":{},"ISSN":["0022-3956"],"issn-type":[{"value":"0022-3956","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated serotonin 1A receptor binding in borderline personality disorder co-morbid with major depressive episodes appears attributable to major depression alone","name":"articletitle","label":"Article Title"},{"value":"Journal of Psychiatric Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpsychires.2026.05.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}